| Literature DB >> 35631023 |
Chelea Matchawe1, Eunice M Machuka2, Martina Kyallo2, Patrice Bonny1, Gerard Nkeunen3, Isaac Njaci2, Seraphine Nkie Esemu4, Dedan Githae2, John Juma2, Bawe M Nfor5, Bonglaisin J Nsawir1, Marco Galeotti6, Edi Piasentier6, Lucy M Ndip4, Roger Pelle2.
Abstract
One of the crucial public health problems today is the emerging and re-emerging of multidrug-resistant (MDR) bacteria coupled with a decline in the development of new antimicrobials. Non-typhoidal Salmonella (NTS) is classified among the MDR pathogens of international concern. To predict their MDR potentials, 23 assembled genomes of NTS from live cattle (n = 1), beef carcass (n = 19), butchers' hands (n = 1) and beef processing environments (n = 2) isolated from 830 wet swabs at the Yaounde abattoir between December 2014 and November 2015 were explored using whole-genome sequencing. Phenotypically, while 22% (n = 5) of Salmonella isolates were streptomycin-resistant, 13% (n = 3) were MDR. Genotypically, all the Salmonella isolates possessed high MDR potentials against several classes of antibiotics including critically important drugs (carbapenems, third-generation cephalosporin and fluoroquinolone). Moreover, >31% of NTS exhibited resistance potentials to polymyxin, considered as the last resort drug. Additionally, ≤80% of isolates harbored "silent resistant genes" as a potential reservoir of drug resistance. Our isolates showed a high degree of pathogenicity and possessed key virulence factors to establish infection even in humans. Whole-genome sequencing unveiled both broader antimicrobial resistance (AMR) profiles and inference of pathogen characteristics. This study calls for the prudent use of antibiotics and constant monitoring of AMR of NTS.Entities:
Keywords: Yaounde abattoir; beef carcass; multidrug-resistance; non-typhoidal Salmonella; pathogenicity and virulence; silent resistant genes; whole-genome sequencing
Year: 2022 PMID: 35631023 PMCID: PMC9148033 DOI: 10.3390/pathogens11050502
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Antimicrobial sensitivity of non-typhoidal Salmonella isolated at the Yaounde abattoir.
| Sample Code | Tetracycline | Chloramphenicol | Streptomycin | Ampicillin | |
|---|---|---|---|---|---|
| 34ev | Wernigerode |
|
|
|
|
|
|
|
|
|
|
|
| 35dea | Wilhelmsburg |
|
|
|
|
| 35deb | Wilhelmsburg |
|
|
|
|
|
|
|
|
|
|
|
| 31eva | Wilhelmsburg |
|
|
|
|
| 31evb | Wilhelmsburg |
|
|
|
|
| 32eva | Wilhelmsburg |
|
|
|
|
| 32evb | Wernigerode |
|
|
|
|
| 86ev | Infantis |
|
|
|
|
| 100ev | Wernigerode |
|
|
|
|
| 36ev | Wilhelmsburg |
|
|
|
|
| 98se | Wernigerode |
|
|
|
|
| 108ev | Kibusi |
|
|
|
|
| 20de | Enteritidis |
|
|
|
|
|
|
|
|
|
|
|
| 60sa | Enteritidis |
|
|
|
|
| 88sa | Infantis |
|
|
|
|
| 88sab | Infantis |
|
|
|
|
| 133sa | Enteritidis |
|
|
|
|
| 103bo | Wilhelmsburg |
|
|
|
|
| EVJUL | Mbandaka |
|
|
| |
| DEF1 | Not sequenced |
|
|
|
|
NB: + indicates resistance to the test antibiotic; I = intermediate isolates; − susceptible isolates; code and serovar of Salmonella strain written in red, represent the multidrug-resistant (MDR) strains.
Distribution of resistance genes against specific antibiotic across Salmonella isolates in the study.
| Antibiotics | Resistance Genes | 8ev | 20de | 22sa | 31eva | 31evb | 32eva | 32evb | 34de | 34ev | 35dea | 35deb | 36ev | 60sa | 88sa | 88sab | 98se | 100ev | 103bo | 108ev |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poona | Enteritidis | Poona | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | wernigerode | Poona | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Enteritidis | Infantis | Infantis | wernigerode | wernigerode | Wilhelmsburg | Kibusi | ||
| STR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| CHL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| TE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| AMP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
, detected presence of resistance gene; − , resistance gene not detected; , false negative; AMP = Ampicillin; CHL = Chloramphenicol; STR = Streptomycin; TE = Tetracycline.
Matching antibiotic susceptibility test with genotypic resistance potentials of Salmonella isolates.
| Antibiotics | Number of Test Results | Sensitivity (%) | Specificity (%) | Negative PV (%) | Positive PV (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Resistant Phenotype Sensitive Phenotype | ||||||||||
| Genotype | Genotype | Genotype | Genotype | Odds Ratio | ||||||
| STR | 5 | 0 | 3 | 11 | 4.0 | 0.46 | 62.5 | 100 | 78.6 | 100 |
| AMP | 3 | 0 | 3 | 13 | 50 | 100 | 81.2 | 100 | ||
| CHL | 3 | 0 | 5 | 11 | 62.5 | 100 | 68.7 | 100 | ||
| TE | 3 | 0 | 15 | 1 | 16.7 | 100 | 6.2 | 100 | ||
Key: Sensitivity = TP/(TP + FN) × 100; Specificity = TN/(FP + TN) × 100; PPV = TP/(TP + FP) × 100; NPV = TN/(FN + TN) × 100; TP = True positive; FP = False positive; TN = True negative; FN = False negative; PPV = Positive predictive value; NPV = Negative predictive value.
Distribution of multidrug resistance genes among Salmonella serotypes.
| Class of Antibiotic | Resistance Gene | 8ev | 20de | 22sa | 31eva | 31evb | 32eva | 32evb | 34de | 34ev | 35dea | 35deb | 36ev | 60sa | 88sa | 88sab | 98se | 100ev | 103bo | 108ev |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poona | Enteritidis | Poona | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Wernigerode | Poona | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Enteritidis | Infantis | Infantis | Wernigerode | Wernigerode | Wilhelmsburg | Kibusi | ||
| Aminoglycosides |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Phenicol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Tetracycline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| β-lactam |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
| Fluoroquinolone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Sulfa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Macro |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| PMB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
= Presence multiple resistance gene; − = no multiple resistance gene detected; Sulfa = Sulfonamide; PMB = Polymyxin B; Genes in purple = multiple resistance genes; genes in red = genes coding resistance against antibiotics high concern by WHO; Genes in black = represent genes that code resistance against not more than one class of antibiotics.
Polymorphism in Salmonella serovars with potential resistance to polymyxins.
| Isolate Code | Position of Mutation on pmrA & pmrB | Nucleotide Change | Amino Acid Change |
|---|---|---|---|
| 8ev | pmrB | ||
| pmrB p.M15T | ATG → ACT | M → T | |
| pmrB p.G73S | GGC → AGC | G → S | |
| pmrB p.V74I | GTA → ATA | V → I | |
| pmrA | |||
| pmrA p.T89S | ACC → AGC | T → S | |
| 22sa | pmrB | ||
| pmrB p.M15T | ATG → ACT | M → T | |
| pmrB p.G73S | GC → AGC | G → S | |
| pmrB p.A111T | GCG → ACG | A→ T | |
| pmrA | |||
| pmrA p.T89S | ACC → AGC | T → S | |
| 31eva | pmrB | ||
| pmrB p.M15T | ATG→ACT | M → T | |
| pmrB p.G73S | GGC → AGC | G → S | |
| pmrB p.V74I | GTA → ATA | V →I | |
| pmrB p.A111T | GCG →ACG | A → T | |
| pmrA p.T89S | ACC → AGC | T → S | |
| 32eva | pmrB | ||
| pmrB p.I18L | ATT→CTT | I → L | |
| 34de | pmrB | ||
| pmrB p.M15T | ATG → ACT | M → T | |
| pmrB p.G73S | GGC → AGC | G → S | |
| pmrB p.V74I | GTA → ATA | V → I | |
| pmrB p.A111T | GCG → ACG | A → T | |
| pmrB p.L352M | CTG → ATG | L → M | |
| pmrA | |||
| pmrA p.T89S | ACC → AGC | T → S | |
| 35dea | pmrB | ||
| pmrB p.V126G | GTC → GGC | V → G | |
| pmrB p.S127A | TCG → GCG | S → A | |
| pmrB p.I129L | ATC → CTC | I → L | |
| pmrB p.V133D | GTT → GAT | V → D | |
| pmrB p.L136R | TTG → AGG | L → R | |
| pmrB p.T139P | ACG → CCG | T → P |
Prediction of Salmonella isolates as human pathogens.
| Serovars | PHPathogen | Proteome Coverage (%) | Matched PF | Non PF |
|---|---|---|---|---|
| Poona | 0.93 a | 10.1 | 466 | 5 |
| Enteritidis | 0.95 a | 18.2 | 787 | 2 |
| Wilhelmsburg | 0.94 a | 15.71 | 691 | 3 |
| Wernigerode | 0.94 a | 15 | 661 | 3 |
| Infantis | 0.94 a | 17.45 | 746 | 3 |
| Kibusi | 0.94 a | 18 | 778 | 3 |
Key: PHPathogen = predicted as human pathogen; PF = pathogenic family; NPF = Non pathogenic family. Values with the same superscript letters are not significantly different (p > 0.05).
Virulence factors among Salmonella serovars.
| Function Category | 8ev | 20de | 22sa | 31eva | 31evb | 32eva | 32evb | 34de | 34ev | 35dea | 35deb | 36ev | 60sa | 88sa | 88sab | 98se | 100ev | 103bo | 108ev | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Locus | Poona | Enteritidis | Poona | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Wernigerode | Poona | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Wilhelmsburg | Enteritidis | Infantis | Infantis | Wernigerode | Wernigerode | Wilhelmsburg | Kibusi | |
| SPI-1 | 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-2 | 14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-3 | 15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-3 | 16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-3 | 15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-4 | 17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-5 | 18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-8 | 21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-9 | 22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-13 | 9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-13 | 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-13 | 11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-14 | 12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPI-14 | 13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C63PI | 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ = detected presence of virulence factor; − = Virulence factor not detected.